Incyte Corp
XMUN:ICY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Incyte Corp
XMUN:ICY
|
US |
|
T
|
Telenor ASA
XMUN:TEQ
|
NO |
|
Siloam International Hospitals Tbk PT
F:2LS
|
ID |
|
CBRE Group Inc
NYSE:CBRE
|
US |
|
A
|
Acea SpA
F:DCA
|
IT |
Wall St Price Targets
ICY Price Targets Summary
Incyte Corp
According to Wall Street analysts, the average 1-year price target for ICY is 93.92 EUR with a low forecast of 62.02 EUR and a high forecast of 120.7 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ICY's stock price target?
Price Target
93.92
EUR
According to Wall Street analysts, the average 1-year price target for ICY is 93.92 EUR with a low forecast of 62.02 EUR and a high forecast of 120.7 EUR.
What is the Revenue forecast for Incyte Corp?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Incyte Corp?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 73%. The projected CAGR for the next 8 years is 8%.
What is the Net Income forecast for Incyte Corp?
Projected CAGR
4%
The compound annual growth rate for Net Income over the next 8 years is 4%.
